More Articles

Access and Evidence

Value: A Balancing Act

Ross Davies, (Oct 16, 2018)

When it comes to proving the value of a new medicine, pharma has to strike the right balance
Access and Evidence

Can Payers Trust Our Data?

Andrew Stone, (Oct 16, 2018)

Analyses from RWD are playing an increasingly important role, but will payers accept pharma’s figures?
Access and Evidence

Diving for Data

Andrew Stone, (Oct 16, 2018)

Finding the right data to underpin outcome-based contracts is not as easy as it looks
Access and Evidence

Rid Yourself Of Dirty Data

Andrew Stone, (Oct 11, 2018)

Real-world data holds enormous potential. But it also risks being riddled with bias.
Patients and Medical

The Discovery That Changed My Life

Lucy Fulford, (Oct 8, 2018)

For Rocco Falchetto, stepping into the sun was extremely painful. Then one day, everything changed.
Patients and Medical

Patients: The New Architects Of Clinical Trials?

Danielle Barron, (Oct 4, 2018)

The industry has long flirted with the idea of getting patients to design clinical trials. But is the idea coming to fruition?

The Sales Force of The Future

Katie Osborne, (Oct 1, 2018)

What does a truly digitally mature sales force look like and how can companies transform their current force into one?
Patients and Medical

Are Your MSLs The Real Deal?

Adam Chapman, (Sep 27, 2018)

An MSL must ooze authenticity. Science depends on it.
Patients and Medical

A Career-Defining Diagnosis

Hugh Gosling, (Sep 26, 2018)

Roche's Jay Graves doesn't just live with diabetes, he works with it. This is his story.

Would Your Reps Pass The Empathy Test?

Ross Davies, (Sep 19, 2018)

Understanding the patient experience is vital for the modern sales rep